Conclusions
Proteome analysis of HCC is an emerging area of research in the discovery of novel proteins as early biomarkers for diagnosis and potential therapeutic targets for the treatment of HCC. Although numerous publications have appeared on the gene expression analysis of HCC by cDNA microarrays, there is still a need to analyze the differentially expressed proteins in the cellular proteome as many protein modifications are not reflected by changes at the RNA level. New and improved proteomic technologies such as DIGE, and ICAT labelling in combination with mass spectrometric analysis will drive and accelerate the next phase of expression profiling of HCC. There will also be a concerted effort in performing proteome analysis at the subcellular level (subproteomics) in order to detect and identify low abundance proteins which may be missed at the global expression profile of the whole cell. In addition the localization sites of these identified proteins will provide clues to their functions. Finally, it is hoped that integration of proteome-based approaches with data from genomic profiling will lead to a better understanding of hepatocarcinogenesis which will then contribute to the direct translation of the research findings into clinical practice (Selinger and Kellner, 2002).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beasley, R.P., Hwang, L.Y., Lin, C.C., and Chien, C.S., 1981, Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet, 2: 1129–1133.
Chen, X., Cheung, S.T., So, S., Fan, S.T., Barry, C., Higgins, J., Lai, K.-M., Ji, J., Dudoit, S., Ng, I.O.L., van de Rijn, M., Botstein, D., and Brown, P.O., 2002, Gene expression patterns in human liver cancers. Mol. Biol. Cell, 13: 1929–1939.
Cho, S.Y., Park, K.-S., Shim, J.E., Kwon, M.-S., Joo, K.H., Lee, W.S., Chang, J., Kim, H., Chung, H.C., Kim, H.O., Paik, Y.-K., 2002, An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management system. Proteomics, 2: 1104–1113.
Choong, M.L., Tan, L.K., Lo, S.L., Ren, E.C., Ou, K., Ong, S.-E., Liang, R.C.M.Y., Seow, T.K., and Chung, M.C.M., 2001, An integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumours. FEBS Letts., 496: 109–116.
Delpuech, O., Trabut, J.-P., Carnot, F., Feuillard, J., Brechot, C., and Kremsdorf, D., 2002, Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene, 21: 2926–2937.
Deuffic, S., Buffat, L., Poynard, T., and Valleron, A.J., 1999, Modeling the hepatitis C virus epidemic in France. Hepatology, 29: 1596–1601.
Dreger, M., 2003, Proteome analysis at the level of subcellular structures. Eur. J. Biochem., 270: 589–599.
Du, M.Q., Hutchinson, W.L., Johnson, P.J., and Williams, R., 1991, Differential α-fetoprotein lectin binding in hepatocellular carcinoma. Cancer, 61: 476–480.
El-Serag, H.B. and Mason, A.C., 1999, Rising incidence of hepatocellular carcinoma in the United States. N. England J. Med., 340: 745–750.
Feitelson, M.A., Sun, B., Tufan, N.L.G., Liu, J., and Lian, Z., 2002, Genetic mechanisms of hepatocarcinogenesis. Oncogene, 21: 2593–2604.
Fukuda, S., Wu, D.W., Stark, K., and Pelus, L.M., 2002, Cloning and characterization of a proliferation-associated cytokine-inducible protein, CIP29. Biochem. Biophys. Res. Commun., 292: 593–600.
Goldenberg, D., Ayesh, S., Schneider, T., Pappo, O., Jurim, O., Eid, A., Fellig, Y., Dadon, T., Ariel, I., de Groot, N., Hochberg, A., and Galun, E., 2002, Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays. Molec. Carcinog., 33: 113–124.
Gray, S.G., 2001, Proteomic payoff. Trends in Genetics, 17: 382–382.
Gygi, S.P., Rochon, Y., Franza, B.R., and Aebersold, R., 1999a, Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol., 19: 1720–1730.
Gygi, S.P., Rist, B., Gerber, S.A., Turecek, F., Gelb, M.H., and Aebersold, R., 1999b, Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol., 17: 994–999.
Ho, S., Cheng, P., Chan, A., Leung, N., Yeo, W., Leung, T., Lau, W.Y., Li, A.K.C. and Johnson, P.J., 1996, Isoelectric focusing of alpha-fetoprotein in patients with hepatocellular carcinoma — frequency of specific banding patterns at non-diagnostic serum levels. Brit. J. Cancer, 73: 985–988.
Ideker, T., Thorsson, V., Ranish, J.A., Christmas, R., Buhler, J., Eng, J.K., Bumgarner, R., Goodlett, D.R., Aebersold, R., and Hood, L., 2001, Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science, 292: 929–934.
Johnson, P.J., Leung, N., Cheng, P., Welby, C., Leung, T., Lau, W.Y., Yu, S., and Ho, S., 1997, ‘Hepatoma-specific’ alpha-fetoprotein may perrmit preclinical diagnosis of malignant change in patients with chronic liver disease. Brit. J. Cancer, 75: 236–242.
Kao, J.-H. and Chen, D.-S., 2002, Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma. Int. J. Cancer, 97: 269–271.
Kim, J., Kim, SA.H., Lee, S.U., Ha, G.H., Kang, D.G., Ha, N.-H., Ahn, J.S., Cho, H.Y., Kang, S.-J., Lee, W.-J., Hong, H.C., Ha, W.S., Bae, J.M., Lee, C.-W., and Kim, J.W., 2002, Proteome analysis of human liver tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization mass spectrometry for identification of diseaserelated proteins. Electrophoresis, 23: 4142–4156.
Kim, M.-Y., Park, E., Park, J.-H., Park, D.-H., Moon, W.-S., Cho, B.-H., Shin, H.-S., and Kim, D.-G., 2001, Expression profile of nine novel genes differentially expressed in hepattis B virus-associated hepatocellular carcinomas. Oncogene, 20: 4568–4575.
Lau, W.-Y., Lai, P.B.S., Leung, M.-F., Leung, B.C.S., Wong, N., Chen, G., Leung, T.W.T., and Liew, C.-T., 2000, Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncology Res., 12: 59–69.
Le Naour, F., Brichory, F.B., Misek, D.E., Brechoy, C., Hanash, S.M., and Beretta, L., 2002, A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol.Cell.Proteomics, 1.3: 197–203.
Li, D., Mallory, T., and Satomura, S., 2001, ALF-L3: a new generation of tumour marker for hepatocellular carcinoma. Clin. Chim. Acta, 313: 15–19.
Liang, R.C.M.Y., Neo, J.C.H., Lo, S.L., Tan, G.S., Seow, T.K., and Chung, M.C.M., 2002, Proteome database of hepatocellular carcinoma. J. Chrom. B, 771: 303–328.
Lim, S,O., Park, S.-J., Kim, W., Park, S.G., Kim, H.-J., Kim, Y.-I., Sohn, T.-S., Noh, J.-H., and Jung, G., 2002, Proteome analysis of hepatocellular carcinoma. Biochem. Biophys. Res. Comm., 291: 1031–1037.
Llovet, J.M. and Beaugrand, M., 2003, Hepatocellular carcinoma: present status and future prospects. J. Hepatology, 38: S136–S149.
McGlynn, K.A., Tsao, L., Hsing, A.W., Devesa, S.S., and Fraumeni, Jr., J.F., 2001, International trends and patterns of primary liver cancer. Int. J. Cancer, 94: 290–296.
Naraki, T., Kohno, N., Saito, H., Fujimoto, Y., Ohhira, M., Morita, T. and Kohgo, Y., 2002, γ-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-γ-carboxy prothrombin. Biochim. Biophys. Acta, 1586: 287–298.
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., and Nakamura, Y., 2001, Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumour progression. Cancer Res., 61: 2129–2137.
Old, L.J., and Chen, Y.T., 1998, New paths in human cancer serology. J. Exp. Med., 187: 1163–1167.
Ou, K., Seow, T.K., Liang, R.C.M.Y., Ong, S.-E., and Chung, M.C.M., 2001, Proteome analysis of a human hepatocellular carcinoma cell line, HCC-M: An update. Electrophoresis, 22: 2804–2811.
Park, K.-S., Cho, S.-Y., Kim, H., and Paik, Y.-K., 2002, Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int. J. Cancer, 97: 261–265.
Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P., 2001, Estimating the world cancer burden: Globocan 2000. Int J. Cancer, 94: 153–156.
Poon, T.C.W., and Johnson, P.J., 2001, Proteome analysis and its impact on the discovery of serological tumour markers. Clin. Chim. Acta, 313: 231–239.
Poon, T.C.W., Mok, T.S.K., Chan, A.T.C., Chan, C.M.L., Leong, V., Tsui, S.H.T., Leung, T.W.T., Wong, H.T.M., Ho, S.K.W. and Johnson, P.J., 2002, Quantitation and utility of monosialylated α-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total α-fetoprotein. Clin. Chemistry, 48: 1021–1027.
Sahin, U., Tureci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I., and Pfreundschuh., 1995, Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci., 92: 1180–1183.
Saitoh, S., Ikeda, K., Koida, I., Tsubota, A., Arase, Y., Chayama, K. and Kumada, H., 1994, Serum des-gamma-carboxy prothrombin concentration determination by avidin-biotin complex in small hepatocellular carcinomas. Cancer, 74: 2918–2923.
Schafer, D.F., and Sorrell, M.F., 1999, Hepatocellular carcinoma. Lancet, 353: 1253–1257.
Selinger, B., and Kellner, R., 2002, Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics, 2: 1641–1651.
Seow, T.K., Ong, S.-E., Liang, R.C.M.Y., Ren, E.-C., Chan, L., Ou, K., and Chung, M.C.M., 2000, Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell libe, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis, 21: 1787–1813.
Seow, T.K., Liang, R.C.M.Y., Leow, C.K., and Chung, M.C.M., Hepatocellular carcinoma: from bedside to proteomics. Proteomics, 1: 1249–1263.
Shirota, Y., Kaneko, S., Honda, M., Kawai, H.F., and Kobayashi, K., 2001, Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology, 33: 832–840.
Simpson, R.J., and Dorow, D.S., 2001, Cancer proteomics: from signalling networks to tumour markers. Trends in Biotechnol, 19: S40–S48.
Steel, L.F., Mattu, T.S., Mehta, A., Hebestreit, H., Dwek, R., Evans, A.A., London, W.L., and Block, T., 2001, A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis. Markers, 17: 179–189.
Stenner-Liewen, F., Luo, G., Sahin, U., Tureci, O., Koslovski, I., Kautz, I., Liewen, H., and Pfreundschuh, M., 2000, Definition of tumour-associated antigens in hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev., 9: 285–290.
Tackels-Horne, D., Goodman, M.D., Williams, A.J., Wilson, D.J., Eskandari, T., Vogt, L.M., Boland, J.F., Scherf, U., and Vockley, J.G., 2001, Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer, 92: 395–405.
Thorgeirsson S.S. and Grisham, J.W., 2002, Molecular pathogenesis of human hepatocellular carcinoma. Nature Genetics, 31: 339–346.
Tonge, R., Shaw, J., Middleton, B., Rowlinson, R., Rayner, S., Young, J., Pognan, F., Hawkins, E., Currie, I., and Davison, M. 2001, Validation and development of fluorescent two-dimensional differential gel electrophoresis proteomics technology. Proteomics, 1: 377–396.
Unlu, M., Morgan, M.E., and Minden, J.S., 1997, Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis, 18: 2071–2077.
Wang, Y., Han, K.-J., Pang, X.-W., Vaughan, H.A., Qu, W., Dong, X.-Y., Peng, J.-R., Zhao, H.-T., Rui, J.-A., Leng, X.-S., Cebon, J., Burgess, A.W., and Chen, W.-F., 2002, Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J. Immunol., 169: 1102–1109.
Watanabe, T., Morizane, T., Tsuchimoto, K., Inagaki, Y., Munakata, Y., Nakamura, T., Kumagai, N., and Tsuchiya, M., 1983, Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma. Int.J. Cancer, 32: 141–146.
Wirth, P.J., Hoang, T.N., and Benjamin, T., 1995, Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins. Electrophoresis, 16: 1946–1960.
Xu, X.-R., Huang, J., Xu, Z.-G., Qian, B.-Z., Zhu, Z.-D., Yan, Q., Cai, T., Zhang, X., Xiao, H.-S., Qu, J., Liu, F., Huang, Q.-H., Cheng, Z.-H., Li, N.-G., Du, J.-J., Hu, W., Shen, K.-T., Lu, G., Zhong, M., Xu, S.-H., Gu, W.-Y., Huang, W., Zhao, X.T., Hspu, G.-X., Gu, J.-R., Chen, Z., and Han, Z.-G., 2001, Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci., 98: 15089–15094.
Yano, N., Habib, N.A., Fadden, K.J., Yamashita, H., Mitry, R., Jauregui, H., Kane, A., Endoh, M., and Rifai, A., 2001, Profiling of the human adult liver transcriptome: analysis by cDNA array hybridization. J. Hepatology, 35: 178–186.
Yu, L.-R., Zeng, R., Shao, X.-X., Wang, N., Xu, Y.-H., Xia, Q.-C., 2000, Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis, 21: 3058–68.
Yu, L.-R., Shao, X.-X., Jiang, W.-L., Xu, D., Chang, Y.-C., Xu, Y.-H., and Xia, Q.-C., 2001, Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence. Electrophoresis, 22: 3001–3008.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Chung, M.C.M., Liang, R.C.M.Y., Seow, T.K., Neo, J.C.H., Lo, S.L., Tan, G.S. (2004). Proteomics of Hepatocellular Carcinoma: Present Status and Future Prospects. In: Hondermarck, H. (eds) Proteomics: Biomedical and Pharmaceutical Applications. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2323-5_7
Download citation
DOI: https://doi.org/10.1007/1-4020-2323-5_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-2322-4
Online ISBN: 978-1-4020-2323-1
eBook Packages: Springer Book Archive